Heaton, Luo, and Colleagues Develop Strategy That Could Lead to Universal Flu Shot

MGM faculty Nick Heaton, postdoc Zhaochen Luo, and colleagues have opened a new avenue in the attack against influenza by creating a vaccine that targets a less variable portion of the virus surface. The approach may lead to more broadly protective influenza vaccines and less reliance on an annual shot tailored to that year’s versions of the virus.

This new vaccine approach, described May 1 in the journal Science Translational Medicine, is part of a 5-year-old effort to develop a longer-lasting universal flu vaccine that would be able to foil all versions of the virus.

Click here to read more.